✦ LIBER ✦

Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control

✍ Scribed by Hsu, I-Lin; Su, Wu-Chou; Yan, Jing-Jou; Chang, Jia-Ming; Lai, Wu-Wei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of intrapleural paclitaxe

✍ R.-P. Perng; Y.-M. Chen; M.-F. Wu; K.-C. Chou; W.-C. Lin; J.M. Liu; J. Whang-Pen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 764 KB

ATP-bioluminescence assay indicates the

✍ Jing Zhu; Lixia Ma; Ying Cheng 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 196 KB

The prognostic significance of malignant

✍ Fukuse, Tatsuo; Hirata, Toshiki; Tanaka, Fumihiro; Wada, Hiromi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Plasma and Pleural Fluid Pharmacokinetic

✍ Katsuhiro Masago; Yosuke Togashi; Masahide Fukudo; Tomohiro Terada; Kaoru Irisa; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 286 KB

P-677 Intrapleural hypotonic cisplatin t

✍ Ebi, Noriyuki; Seto, Takashi; Yamamoto, Hidehiko; Ito, Kazunobu; Araki, Jun; Ush 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A phase I clinical and pharmacokinetic s

✍ Xianhuo Wang; Junchao Zhou; Yongsheng Wang; Zhengyan Zhu; You Lu; Yuqan Wei; Lij 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 173 KB